Journal of Infection and Public Health
Volume 1, Issue 1 , Pages 40-44 , 2008

Nasopharyngeal carriage rate of Streptococcus pneumoniae in children with sickle cell disease before and after the introduction of heptavalent pneumococcal conjugate vaccine

  • Ellie Alexander

      Affiliations

    • Academic Unit of Child Health, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, The Blizard Building, 4 Newark Street, London E1 2AT, UK
    • ,
  • Paul Telfer

      Affiliations

    • Department of Paediatric Haematology, Royal London Hospital, London, UK
    • ,
  • Harunor Rashid

      Affiliations

    • Academic Unit of Child Health, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, The Blizard Building, 4 Newark Street, London E1 2AT, UK
    • Corresponding Author InformationCorresponding author. Tel.: +44 2078822615; fax: +44 2078822195.
    • ,
  • Kamal A. Ali

      Affiliations

    • Academic Unit of Child Health, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, The Blizard Building, 4 Newark Street, London E1 2AT, UK
    • ,
  • Robert Booy

      Affiliations

    • Academic Unit of Child Health, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, The Blizard Building, 4 Newark Street, London E1 2AT, UK
    • National Centre for Immunisation Research & Surveillance (NCIRS), Children’s Hospital Westmead and University of Sydney, Australia

Received 12 August 2008 ,Revised 20 August 2008 ,Accepted 21 August 2008.

References 

  1. Zarkowsky HS, Gallagher D, Gill FM, et al. Bacteremia in sickle hemoglobinopathies. J Pediatr. 1986;109:579–585
  2. Davies EG, Riddington C, Lottenberg R, Dower N . Pneumococcal vaccines for sickle cell disease. Cochrane Database Syst Rev. 2004;1:CD003885
  3. Adamkiewicz TV, Sarnaik S, Buchanan GR, et al. Invasive pneumococcal infections in children with sickle cell disease in the era of penicillin prophylaxis, antibiotic resistance, and 23-valent pneumococcal polysaccharide vaccination. J Pediatr. 2003;143:438–444
  4. Peltola H, Booy R, Schmitt HJ. What can children gain from pneumococcal conjugate vaccines?. Eur J Pediatr. 2004;163:509–516
  5. Bjornson AB, Falletta JM, Verter JI, et al. Serotype-specific immunoglobulin G antibody responses to pneumococcal polysaccharide vaccine in children with sickle cell anemia: effects of continued penicillin prophylaxis. J Pediatr. 1996;129:828–835
  6. Finn A, Booy R, Moxon R, Sharland M, Heath P. Should the new pneumococcal vaccine be used in high-risk children?. Arch Dis Child. 2002;87:18–21
  7. Gaston MH, Verter JI, Woods G, et al. Prophylaxis with oral penicillin in children with sickle cell anemia. A randomized trial. N Engl J Med. 1986;314:1593–1599
  8. Hofmann J, Cetron MS, Farley MM, et al. The prevalence of drug-resistant Streptococcus pneumoniae in Atlanta. N Engl J Med. 1995;333:481–486
  9. O’Brien KL, Swift AJ, Winkelstein JA, et al. Safety and immunogenicity of heptavalent pneumococcal vaccine conjugated to CRM(197) among infants with sickle cell disease. Pneumococcal Conjugate Vaccine Study Group. Pediatrics. 2000;106:965–972
  10. Nowak-Wegrzyn A, Winkelstein JA, Swift AJ, Lederman HM. Serum opsonic activity in infants with sickle-cell disease immunized with pneumococcal polysaccharide protein conjugate vaccine. The Pneumococcal Conjugate Vaccine Study Group. Clin Diagn Lab Immunol. 2000;7:788–793
  11. Pai VB, Heyneman CA, Erramouspe J. Conjugated heptavalent pneumococcal vaccine. Ann Pharmacother. 2002;36:1403–1413
  12. Vernacchio L, Neufeld EJ, MacDonald K, et al. Combined schedule of 7-valent pneumococcal conjugate vaccine followed by 23-valent pneumococcal vaccine in children and young adults with sickle cell disease. J Pediatr. 1998;133:275–278
  13. Whitney CG, Farley MM, Hadler J, et al. Decline in invasive pneumococcal disease after the introduction of protein-polysaccharide conjugate vaccine. N Engl J Med. 2003;348:1737–1746
  14. Telfer P, Coen P, Chakravorty S, et al. Clinical outcomes in children with sickle cell disease living in England: a neonatal cohort in East London. Haematologica. 2007;92:905–912
  15. Fey P. New NCCLS interpretive Standards for Streptococcus pneumoniae. Available from http://www.nphl.org/documents/NewNCCLSInterpretiveStandardsForStreptococcuspnewumoniae-Fey.pdf [accessed August 19, 2008].
  16. Anglin DL, Siegel JD, Pacini DL, Smith SJ, Adams G, Buchanan GR. Effect of penicillin prophylaxis on nasopharyngeal colonization with Streptococcus pneumoniae in children with sickle cell anemia. J Pediatr. 1984;104:18–22
  17. Dunais B, Carsenti-Dellamonica H, Bruno P, et al. Mode de garde et portage naso-pharyngé de S. pneumoniae et H. influenzae d’enfants dans les Alpes-Maritimes. Presse Med. 2004;33:1425–1430
  18. Regev-Yochay G, Raz M, Dagan R, et al. Nasopharyngeal carriage of Streptococcus pneumoniae by adults and children in community and family settings. Clin Infect Dis. 2004;38:632–639
  19. Steele RW, Warrier R, Unkel PJ, et al. Colonization with antibiotic-resistant Streptococcus pneumoniae in children with sickle cell disease. J Pediatr. 1996;128:531–535
  20. Lakshman R, Murdoch C, Race G, Burkinshaw R, Shaw L, Finn A. Pneumococcal nasopharyngeal carriage in children following heptavalent pneumococcal conjugate vaccination in infancy. Arch Dis Child. 2003;88:211–214
  21. Grivea IN, Panagiotou M, Tsantouli AG, Syrogiannopoulos GA. Impact of heptavalent pneumococcal conjugate vaccine on nasopharyngeal carriage of penicillin-resistant Streptococcus pneumoniae among day-care center attendees in central Greece. Pediatr Infect Dis J. 2008;27:519–525
  22. Adamkiewicz TV, Silk BJ, Howgate J, et al. Effectiveness of the 7-valent pneumococcal conjugate vaccine in children with sickle cell disease in the first decade of life. Pediatrics. 2008;121:562–569
  23. Halasa NB, Shankar SM, Talbot TR, et al. Incidence of invasive pneumococcal disease among individuals with sickle cell disease before and after the introduction of the pneumococcal conjugate vaccine. Clin Infect Dis. 2007;44:1428–1433
  24. Martens P, Worm SW, Lundgren B, Konradsen HB, Benfield T. Serotype-specific mortality from invasive Streptococcus pneumoniae disease revisited. BMC Infect Dis. 2004;4:21
  25. Bogaert D, Veenhoven RH, Sluijter M, et al. Molecular epidemiology of pneumococcal colonization in response to pneumococcal conjugate vaccination in children with recurrent acute otitis media. J Clin Microbiol. 2005;43:74–83
  26. Choo S, Finn A. New pneumococcal vaccines for children. Arch Dis Child. 2001;84:289–294
  27. Madhi SA, Levine OS, Hajjeh R, Mansoor OD, Cherian T. Vaccines to prevent pneumonia and improve child survival. Bull World Health Organ. 2008;86:365–372

☆ Part of this study was presented at the 10th Congress of the European Hematology Association Stockholm, Sweden, June 2–5, 2005.

PII: S1876-0341(08)00006-3

doi: 10.1016/j.jiph.2008.08.005

Journal of Infection and Public Health
Volume 1, Issue 1 , Pages 40-44 , 2008

Article Tools